Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast
This is a multicenter, phase I/II trial of anastrozole, palbociclib, trastuzumab, and pertuzumab is proposed as first-line therapy in metastatic hormone receptor-positive, HER2-positive breast cancer patients. In this phase I/II clinical trial, the researchers aim to es...
Age: 18 years - 66+
Gender: All
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
Background:
- Laboratory investigators who are studying common childhood cancers are interested in
developing a tissue repository to collect and store blood, serum, tissue, urine, or
tumors of children who have cancer or adults who have common childhood cancers. To...
Age: 4 weeks - 66+
Gender: All
Comprehensive Omics Analysis of Pediatric Solid Tumors and Establishment of a Repository for Related Biological Studies
Background:
- Laboratory investigators who are studying common childhood cancers are interested in
developing a tissue repository to collect and store blood, serum, tissue, urine, or
tumors of children who have cancer or adults who have common childhood cancers. To...
Age: 4 weeks - 66+
Gender: All